Monday, September 19, 2016

BRIEF-Cantargia prepares intensified development strategy and capital raising

* Expands its initial clinical phase I/IIa study of CAN04 with combination therapies

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)